Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation

计划入组 155 人 · 首次发布于 2025 年 9 月 9 日

ZETA : Prospective Observational Study

计划入组 120 人 · 首次发布于 2018 年 11 月 5 日

Tacrolimus in CD3+ T Lymphocytes

计划入组 28 人 · 首次发布于 2024 年 4 月 2 日

Axicabtagene ciloleucel(Yescarta)

Rx

Zeta-BC-003

IGM Biosciences

United States

Beta Bionics

Beta Innov

France

Eureka's ARTEMIS CAR T Cells Demonstrate 16-Fold Superior Tumor Infiltration in Neuroblastoma Study

Over 220 Pipeline Therapies in Development for Non-Hodgkin's Lymphoma, Reports DelveInsight

Latent EBV Infection Enhances Anti-CD3 Antibody Efficacy in Type 1 Diabetes